Vaginal Ring Could Protect Women Against HIV, Studies Suggest

USAID’s “IMPACTblog”: Innovative HIV-Prevention Product for Women Could Be New Tool in the Fight for an AIDS-Free Gen
Elizabeth Russell, senior adviser for biomedical prevention technologies in the research division of USAID’s Office of HIV/AIDS, discusses the results and implications of the ASPIRE trial and The Ring Study that tested an antiretroviral vaginal ring for HIV prevention, writing, “This is the first time that two large clinical trials have yielded statistically significant results in finding that a [vaginal ring] can protect against HIV infection. However, we must recognize that these results are only the starting point for further research…” (2/22).

Center for Global Health Policy’s “Science Speaks”: CROI 2016: Vaginal microbicide ring protects against HIV some of the time, among women who use it, some of the time…
Antigone Barton, senior writer and editor at “Science Speaks,” discusses results from the two vaginal ring studies, which researchers presented on Monday at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston (2/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.